Articles From: Cornerstone OnDemand Management to Present at UBS Global Technology Conference to Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program


Cornerstone OnDemand (NASDAQ:CSOD), a global leader in cloud-based talent management software solutions, today announced that the company’s founder and CEO, Adam Miller, will present at the following investor conference: An audio webcast of the presentation will be available on Cornerstone OnDemand’s investor relations website at http://investors.cornerstoneondemand.com/events.cfm .
Sign-up for Cornerstone OnDemand Management to Present at UBS Global Technology Conference investment picks
http://media.marketwire.com/attachments/201410/282155_logo1.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159677&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for CORRECTION - AMD to Present at Upcoming Financial Conferences investment picks
2014/11/17
JD.com swung to a net loss in the June-September quarter.
Sign-up for Correction to JD.com Article investment picks
http://media.marketwire.com/attachments/200807/428976_COTt.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159189&ProfileId=051205&sourceType=1 TORONTO, ON and TAMPA, FL --
Sign-up for Cott Announces Date for DS Services Modeling Conference Call investment picks
http://media.marketwire.com/attachments/201102/21554_craylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159290&ProfileId=051205&sourceType=1 SEATTLE, WA --
Sign-up for Cray Awarded $80 Million Contract From King Abdullah University of Science and Technology (KAUST) investment picks
2014/11/17
(FROM THE WALL STREET JOURNAL 11/18/14) By John Kester --
Sign-up for Credits & Debits investment picks
2014/11/17
DALLAS , Nov.
Sign-up for Cross Timbers Royalty Trust Declares November Cash Distribution investment picks
MOSCOW, Nov.
Sign-up for CTC Media Announces Development of Licensing Business investment picks
Mr. Reynolds has led CTG Health Solutions Business Since 2011 BUFFALO, N.Y. , Nov.
Sign-up for CTG Names Ted Reynolds a Senior Vice President investment picks
SEATTLE , Nov.
Sign-up for CTI BioPharma to Present at the Upcoming Investor Conferences investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026608-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/17/11G026608/88151fa038d1f3b6_org-828593777.jpg COLUMBUS, IN--(Marketwired - November 17, 2014) - Cummins Inc. (NYSE: CMI) today named Tracy Embree President of the Components Group, effective January 1.
Sign-up for Cummins Inc. Names Tracy Embree President, Components Group investment picks
Curis receives final court approval for plan of arrangement with Taseko Canada NewsWire VANCOUVER , Nov.
Sign-up for Curis receives final court approval for plan of arrangement with Taseko investment picks
CVD Equipment Corporation (Nasdaq: CVV ) , a leading provider of standard and custom chemical vapor deposition systems, today announced that it has received in excess of $10.2 Million in new orders during the month November 2014.
Sign-up for CVD Reports $10.2 Million in Orders for November investment picks
2014/11/17
(NASDAQ: CVV – News) CVD Equipment Corporation, a leading provider of custom chemical vapor deposition systems, today announced its financial results for the three and nine months ended September 30, 2014.
Sign-up for CVD Reports 88% Revenue Increase in Q3 investment picks
Spansion's Energy Harvesting Solution to Eliminate Batteries in iBeacon Modules SUNNYVALE, Calif.
Sign-up for Dai Nippon Printing and Spansion Implement Multiple Field Experiments of Indoor Positioning and O2O Services investment picks
2014/11/17
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ:EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced they will present data from their Phase 3 study, "BOW015, a Biosimilar Infliximab, in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses: 54-Week Results of a Randomized, Double-Blind, Active Comparator Study,” at the 2014 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals (ACR/ARHP), November 18, in Boston, MA.
Sign-up for Data from EPIRUS’ Phase 3 Study of BOW015, a biosimilar infliximab, to be Presented as a Late Breaking Poster at the American College of Rheumatology Annual Meeting investment picks
BEACHWOOD, Ohio , Nov.
Sign-up for DDR Announces the Date of its Fourth Quarter Earnings Release and Conference Call investment picks
2014/11/17
Rigrodsky & Long, P.A.: Do you, or did you, own shares of Pacira Pharmaceuticals, Inc. (NASDAQ GS: PCRX )? Did you purchase your shares before April 9, 2012, or between April 9, 2012 and September 24, 2014, inclusive?
Sign-up for DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Pacira Pharmaceuticals, Inc. Of Upcoming Deadline investment picks
2014/11/17
By Dana Mattioli And Dana Cimilluca The most active mergers-and-acquisitions market in years sped into an even higher gear Monday, as companies took advantage of rising stock prices to announce more than $100 billion in takeover deals.
Sign-up for Deal Boom Feeds on Surging Stocks investment picks
2014/11/17
Run with the Ultramarathon Man in Seattle! LAKE SUCCESS, N.Y. , Nov.
Sign-up for Dean Karnazes To Represent The Greek Gods® Brand At The Amica Insurance Seattle Marathon investment picks
Deutsche Bank today announced its appointment as successor depositary bank for the non-capital raising sponsored Level I American Depositary Receipt (ADR) program of Stockholm-based Sandvik AB (Sandvik). Founded in 1862, Sandvik (OTC US: SDVKY) is a high-tech and global engineering group with more than 47,000 employees in more than 130 countries and sales of just over SEK 87 billion in 2013.
Sign-up for Deutsche Bank Appointed as Successor Depositary Bank for the Sponsored Level I American Depositary Receipt Program of Sandvik AB investment picks
2014/11/17
By Eyk Henning FRANKFURT--
Sign-up for Deutsche Bank Ends Trade in Corporate Credit Swaps investment picks
2014/11/17
FRANKFURT--Europe's banks will lag behind U.S. rivals for the next several years because of the eurozone's weak economy and an unfavorable political environment, Deutsche Bank AG's (DB) co-chief executive Juergen Fitschen said Monday.
Sign-up for Deutsche Bank Held Back by Weak Eurozone investment picks
2014/11/17
By Eyk Henning FRANKFURT--Europe's banks will lag behind U.S. rivals for the next several years because of the eurozone's weak economy and an unfavorable political environment, Deutsche Bank AG's (DB) co-chief executive Juergen Fitschen said Monday.
Sign-up for Deutsche Bank Held Back by Weak Eurozone, Strict Banking Laws - Executive investment picks
2014/11/17
By Katy Burne And Eyk Henning An investment blamed for accelerating the 2008 financial crisis is withering as new rules and placid markets push trading elsewhere.
Sign-up for Deutsche Bank Sharply Reduces Trading in Credit Default Swaps -- 2d Update investment picks
2014/11/17
By Katy Burne and Eyk Henning FRANKFURT--Deutsche Bank AG is sharply reducing its trading in credit default swaps, marking a fresh retreat from a market that has been squeezed following the regulatory overhaul prompted by the financial crisis.
Sign-up for Deutsche Bank Sharply Reduces Trading in Credit Default Swaps -- Update investment picks
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leading developer of RNA interference (RNAi) therapeutics, today announced a licensing agreement for Dicerna to use Tekmira’s proprietary lipid nanoparticle (LNP) technology for delivery of DCR-PH1, Dicerna’s investigational product candidate for primary hyperoxaluria type 1 (PH1), a rare, inherited liver disorder that often results in kidney failure, and for which there are no approved therapies.
Sign-up for Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Cornerstone OnDemand Management to Present at UBS Global Technology Conference to Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent